pHR_Gal4UAS_Blinatumomab_PGK_mCherry Citations (1)

Originally described in: Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors.
Roybal KT, Williams JZ, Morsut L, Rupp LJ, Kolinko I, Choe JH, Walker WJ, McNally KA, Lim WA Cell. 2016 Oct 6;167(2):419-432.e16. doi: 10.1016/j.cell.2016.09.011. Epub 2016 Sep 29. PubMed Journal

---

Articles Citing pHR_Gal4UAS_Blinatumomab_PGK_mCherry

Articles
Targeting SARS-CoV-2 infection through CAR-T-like bispecific T cell engagers incorporating ACE2. Dogan M, Kozhaya L, Placek L, Karabacak F, Yigit M, Unutmaz D. Clin Transl Immunology. 2022 Oct 21;11(10):e1421. doi: 10.1002/cti2.1421. eCollection 2022. PubMed

If you have published an article using this material, please email us at to have your article added to this page.